Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PEComa: what do we know so far?

J L Hornick1, C D M Fletcher

  • 1Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.

Histopathology
|December 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, outcome of advanced disease: retrospective study from the Ultra-Rare Sarcoma Working Group.

ESMO open·2024
Same author

Ecological, morpho-agronomical, and bromatological assessment of sorghum ecotypes in Northern Morocco.

Scientific reports·2023
Same author

Ecological, morpho-agronomical, and nutritional characteristics of Sulla flexuosa (L.) Medik. ecotypes.

Scientific reports·2023
Same author

Recent advances in the diagnosis, classification and molecular pathogenesis of cutaneous mesenchymal neoplasms.

Histopathology·2021
Same author

Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.

ESMO open·2021
Same author

Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same journal

Myxoid neoplasms with MAP3K kinase fusion: a study of 39 cases.

Histopathology·2026
Same journal

TROP2 immunoreactivity in pulmonary large cell neuroendocrine carcinoma.

Histopathology·2026
Same journal

Malignant adenomyoepithelioma of the breast: seven cases illustrating morphological diversity and diagnostic challenges.

Histopathology·2026
Same journal

A CRX-positive RB1-deficient bone tumour with a retinoblastoma-like DNA methylation profile.

Histopathology·2026
Same journal

Perivascular epithelioid cell tumours of the genitourinary tract: clinicopathological features and molecular landscape.

Histopathology·2026
Same journal

Navigating diagnostic challenges in low-grade spindle cell lesions of the breast: a retrospective review.

Histopathology·2026
See all related articles

Perivascular epithelioid cell (PEC) tumors, or PEComas, are rare mesenchymal neoplasms with a distinct cell type. This review focuses on PEComas outside common sites and potential indicators of malignant behavior.

Area of Science:

  • Oncology
  • Pathology
  • Cell Biology

Background:

  • Perivascular epithelioid cell (PEC) tumors, or PEComas, represent a spectrum of mesenchymal neoplasms characterized by a unique cell of uncertain lineage.
  • These tumors, including angiomyolipoma and clear cell 'sugar' tumor, share distinctive morphology and immunophenotype, often expressing both melanocytic and smooth muscle markers.
  • PEComas exhibit a female predominance and typically arise in visceral locations, soft tissues, and skin, with a subset demonstrating malignant potential.

Purpose of the Study:

  • To review the diverse family of PEComas, emphasizing those occurring outside the kidney, lung, and liver.
  • To discuss the pathological features and immunophenotypic characteristics of PEComas.
  • To explore preliminary evidence for predicting malignant behavior in PEComas.

Related Experiment Videos

Main Methods:

  • Literature review of PEComa family members.
  • Analysis of morphological and immunophenotypic features.
  • Examination of clinical behavior and prognostic indicators.

Main Results:

  • PEComas are defined by the presence of perivascular epithelioid cells (PECs) with a characteristic immunoprofile (HMB-45/melan-A and actin/desmin).
  • Common sites include visceral organs (GI, uterus), retroperitoneum, abdominopelvic region, soft tissues, and skin.
  • A subset of PEComas exhibit malignant characteristics, necessitating identification of predictive pathological features.

Conclusions:

  • PEComas are a distinct group of mesenchymal neoplasms with a unique cell type and immunophenotype.
  • Understanding the distribution and pathological features of PEComas, particularly those in less common sites, is crucial.
  • Further research into predictive markers for malignant PEComas is warranted for improved patient management.